Skip to content
OptiPin app icon OptiPin
Download

PT-141 and Melanotan II together

What OptiPin's sourced rule file says about PT-141 with Melanotan II (bremelanotide with MT-2): the combination first, then what each one adds alone, then one bloodwork plan for both. It names markers and red flags, never doses.

This page describes a pair, not you. If you have chest pain, trouble breathing, weakness or numbness on one side, yellowing of your skin or eyes, or shaking, sweating and confusion that could be low blood sugar, get urgent medical care now. Nothing here is a dose, a protocol or a safety verdict.

What the rules say about the combination

1 rule fires only when both compounds are present. Each card is rendered from OptiPin's public, sourced rule file. Its labels show the evidence behind each claim (how we label evidence).

Evidence thin · mechanism, animal data or no human data

PT-141 with melanotan Mechanism

Flagged by: PT-141, Melanotan II

Bremelanotide (PT-141) raises blood pressure for several hours after each dose, per its label. Melanotan II is thought to act on overlapping melanocortin receptors, so the two may add together, but no study has tested the pair.

The blood-pressure effect is known for one of the two; the combination is an inference.

Markers to check
  • Blood pressure, especially in the hours after a dose
Get medical care for
  • Severe headache, chest pain or vision changes (emergency services)
Evidence

Thin: label data for PT-141 only; the additive effect is inferred.

Sources (2)

What to monitor on PT-141 and Melanotan II

Every marker the rules above name, listed once. Take it to your clinician or lab.

Add anything else you run in the stack checker, which starts with this pair already filled in.

What each compound is

PT-141 (bremelanotide, Vyleesi). A melanocortin receptor agonist, sold as Vyleesi for low sexual desire in premenopausal women. More on PT-141.

Melanotan II. An unapproved peptide. FDA's list of compounding safety risks cites published case reports of serious adverse events including melanoma, posterior reversible encephalopathy syndrome, sympathomimetic toxidrome and priapism. More on Melanotan II.

On every cycle you log

OptiPin profiles your stack as you log it

Log a cycle in OptiPin and it shows whether the stack converts to estradiol, which compounds are 19-nors or 17α-alkylated, when red cell count tends to climb and when your own production is shut down, each with the marker that reads it. All on-device.

Download on the App Store

Frequently asked questions

Do PT-141 and Melanotan II interact?

Bremelanotide (PT-141) raises blood pressure for several hours after each dose, per its label. Melanotan II is thought to act on overlapping melanocortin receptors, so the two may add together, but no study has tested the pair. The blood-pressure effect is known for one of the two; the combination is an inference.

What is worth monitoring on PT-141 and Melanotan II?

Blood pressure, especially in the hours after a dose.

When should someone on PT-141 and Melanotan II get medical care?

Severe headache, chest pain or vision changes (emergency services).

Related